Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLID Platelet Study
NCT03712618Phase 2Terminated
- Sponsor
- National Institutes of Health
- Start
- Jun 2019
- Primary completion
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of platelets in Thrombocytopenia and platelet transfusion refractoriness (PTR) (2 arms), sponsored by National Institutes of Health. Primary endpoint: Adjusted Platelet Increment Area Under the Curve. Started Jun 2019; status: terminated.
02
Drugs
platelets
03
Conditions
Thrombocytopeniaplatelet transfusion refractoriness (PTR)
Beyond the preview
Go deeper on NCT03712618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03712618.